Sees Q4 revenue $420M-$440M, consensus $456.2M.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IART:
- Integra LifeSciences reports Q3 adjusted EPS 54c, consensus 43c
- Integra LifeSciences narrows 2025 adj EPS view to $2.19-$2.24 from $2.19-$2.29
- IART Upcoming Earnings Report: What to Expect?
- Integra LifeSciences’ Innovative Approach to Ulcer Treatment: A Study Update
- Integra LifeSciences Advances with MIRROR Registry Study on Hematoma Evacuation